Medical Xpress: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation
For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement in symptoms, function, and quality of life, according to a study published online Oct. 30 in the Journal of the American College of Cardiology.
Suzanne V. Arnold, MD, from Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, and colleagues performed an in-depth analysis of the health status of patients enrolled in the TRISCEND II pivotal trial. Patients with symptomatic and severe or greater TR were randomly assigned to TTVR with the EVOQUE tricuspid valve replacement system plus OMT or OMT alone (259 and 133 patients, respectively).
Read the full Medical Xpress article: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation
Relevant News
News
FOX 4: Raising Human Trafficking Awareness During the World Cup
News
KMBC: Health Experts Discuss World Cup Health Risks in Kansas City
News
KMBC: Cardiologist Shares About Broken Heart Syndrome
News
FOX 4: Kansas City Prepping for Extreme Heat Concerns
News
KSHB: ‘It’s a Journey To Be Back’: Family Reflects on 100 Days in NICU More Than 20 Years Ago
News